Although existing treatments such as GLP-1 receptor agonists improve glucose control and promote weight loss, many patients remain inadequately controlled or experience dose-limiting side effects, including nausea and vomiting
9 studies where NAC/GSH is not the primary intervention
Most patients report significant reduction in this symptom by week 8-12 of consistent treatment, as your digestive system recalibrates to the new baseline of gastric transit time
Transformation of caspase-1 precursor into the active enzyme promotes IL-1 maturation and secretion by macrophages, thus controlling pathogen infections (Pepe et al., 2021)
Whilst the medication itself does not appear to deplete iron stores or impair iron metabolism, the physiological and behavioural changes that accompany Wegovy useparticularly significant dietary restriction and gastrointestinal symptomsmay create conditions that affect iron status
This may mean learning mindful eating techniques or picking up healthier stress management strategies
.png)
